COVID-19 vaccine trials: The potential for "hybrid" analyses.

Thomas R FlemingMartha NasonPhilip R KrauseIra M LonginiAna-Maria Henao-Restrepo

Published in: Clinical trials (London, England) (2021)

The proposed hybrid methods could readily play an important role in the near future in the design, conduct and analysis of randomized clinical trials performed to address the need for multiple additional vaccines reliably established to be safe and have worthwhile efficacy in reducing the risk of symptomatic disease from SARS-CoV-2 infections.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
current status
clinical trial
human health